A 58-year-old woman with multiple cardiac risk factors (uncontrolled DM2 10.3 HgbAIC, HTN, lipids), Asthma, Sleep Apnea, and 1 week of worsening DOE was admitted for r/o MI. Her BP was elevated at 150-160's/80-90 and was stabilized with IV lopressor and nitro paste. Her CV- cardiac enz was neg x3- ASA, no BB secondary Asthma. She was prescribed ACETYLSALICYLIC ACID 81 MG PO QD, AMITRIPTYLINE HCL 25 MG PO QHS, FUROSEMIDE 40 MG PO QD, GLYBURIDE 10 MG PO BID, NOVOLIN INNOLET 70/30 (INSULIN 70/30 (HUMAN)) 100 UNITS SC BID (Number of Doses Required (approximate): 8), NORVASC (AMLODIPINE) 10 MG PO QD, and LIPITOR (ATORVASTATIN) 10 MG PO QD. An override notice was added on 6/23/04 by GASTINEAU, RAMIRO, M.D. for CLOTRIMAZOLE 1% CREAM TP (ref # 17426481) due to SERIOUS INTERACTION: ATORVASTATIN CALCIUM & CLOTRIMAZOLE, and an override was added on 6/23/04 by ARDELEAN, TRACY, M.D. for LIPITOR PO (ref # 90735952) due to Pt. having a PROBABLE allergy to SIMVASTATIN; reaction is myalgia. The patient was discharged with a diagnosis of r/o MI, SOB multifactorial deconditioning, pulmon disease, HTN, uncontrolled DM, Sleep Apnea, Asthma, and was given instructions to call her doctor if having chest pain, worsening shortness of breath with exertion or at rest, new onset back/shoulder pain, worsening fatigue or any other concerns. She was also prescribed a diet of House/ADA 2100 cals/dy and told to walk as tolerated. She was told to call her PCP to schedule an out patient Cardiac MIBI with adenosine.
Has patient ever been prescribed clotrimazole
ATORVASTATIN CALCIUM & CLOTRIMAZOLE,